Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2012, Article ID 750891, 10 pages
http://dx.doi.org/10.1155/2012/750891
Review Article

Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery

1Department of Biotechnological Processes, School of Chemical Engineering, State University of Campinas (UNICAMP), 13083-970 Campinas, SP, Brazil
2Faculty of Health Sciences, Fernando Pessoa University (FCS-UFP), Rua Carlos da Maia, 296, 4200-150 Porto, Portugal
3Department of Biology and Environment, University of Trás-os Montes e Alto Douro, 5001-801 Vila Real, Portugal
4Centre for Research and Technology of Agro-Environmental and Biological Sciences, 5001-801 Vila Real, Portugal
5Institute of Biotechnology and Bioengineering, Centre of Genomics and Biotechnology, University of Trás-os-Montes and Alto Douro (CGB-UTAD/IBB), P.O. Box 1013, 5001-801 Vila Real, Portugal

Received 19 July 2011; Revised 5 October 2011; Accepted 5 October 2011

Academic Editor: Rajesh Patil

Copyright © 2012 Patrícia Severino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Eldem, P. Speiser, and A. Hinkal, “Optimization of spray-dried and congelated lipid micropellets and caracterization of their surface morphology by scanning electron microscopy,” Pharmaceutical Research, vol. 8, pp. 47–54, 1991. View at Google Scholar
  2. P. Speiser, EP 0167825, assignee. Lipid nanopellets als Tragersystem fur Arzneimittel zur peroralen Anwendung, 1990.
  3. A. J. Domb, “Long acting injectable oxytetracycline-liposphere formulations,” International Journal of Pharmaceutics, vol. 124, no. 2, pp. 271–278, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. A. J. Domb, “Lipospheres for controlled delivery of substances,” 1993.
  5. A. J. Domb, “Liposphere parenteral delivery system,” Proceedings of the Controlled Release Society, no. 20, pp. 121–122, 1993. View at Google Scholar
  6. K. Manjunath, J. S. Ready, and V. Venkateswarlu, “Solid lipid nanoparticles as drug delivery systems,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 27, no. 2, pp. 127–144, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Qi, L. Wang, and J. Zhu, “Water-in-oil-in-water double emulsions: an excellent delivery system for improving the oral bioavailability of pidotimod in rats,” Journal of Pharmaceutical Sciences, vol. 100, no. 6, pp. 2203–2211, 2011. View at Publisher · View at Google Scholar
  8. M. J. Morilla, D. M. Gomez, P. Cabral et al., “M cells prefer archaeosomes: an in vitro/in vivo snapshot upon oral gavage in rats,” Current Drug Delivery, vol. 8, no. 3, pp. 320–329, 2011. View at Google Scholar
  9. C. F. Da Silva, P. Severino, F. Martins, M. V. Chaud, and M. H. A. Santana, “The intestinal permeation of didanosine from granules containing microspheres using the everted gut sac model,” Journal of Microencapsulation, vol. 26, no. 6, pp. 523–528, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Severino, S. C. Pinho, E. B. Souto, and M. H. A. Santana, “Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles,” Colloids and Surfaces B, vol. 86, no. 1, pp. 125–130, 2011. View at Publisher · View at Google Scholar
  11. P. Severino, S. C. Pinho, E. B. Souto, and M. H. A. Santana, “Crystallinity of Dynasan114 and Dynasan118 matrices for the production of stable Miglyol-loaded nanoparticles,” Journal of Thermal Analysis and Calorimetry. In press.
  12. R. H. Müller, W. Mehnert, J. S. Lucks et al., “Solid lipid nanoparticles (SLN)—an alternative colloidal carrier system for controlled drug delivery,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 41, no. 1, pp. 62–69, 1995. View at Google Scholar · View at Scopus
  13. R. H. Müller and J. S. Lucks, “Azneistoffräger aus festen Lipidteilchen—feste Lipid Nanosphären (SLN),” Germany, 1996.
  14. M. R., inventor Gasco, “Method for producing solid lipid microspheres having a narrow size distribution,” Italy, 1993.
  15. M. Trotta, M. E. Carlotti, M. Gallarate, G. P. Zara, E. Muntoni, and L. Battaglia, “Insulin-loaded SLN prepared with the emulsion dilution technique: in vivo tracking of nanoparticles after oral administration to rats,” Journal of Dispersion Science and Technology, vol. 32, no. 7, pp. 1041–1045, 2011. View at Publisher · View at Google Scholar
  16. E. B. Souto and R. H. Müller, “Lipid nanoparticles—effect on bioavailability and pharmacokinetics changes,” in Handbook of Experimental Pharmacology—Novel Drug Delivery Approaches, M. Schäfer-Korting, Ed., vol. 197, pp. 115–141, Springer, Berlin, Germany, 2009. View at Google Scholar
  17. M. A. Schubert and C. C. Müller-Goymann, “Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 61, pp. 77–86, 2005. View at Google Scholar
  18. R. H. Müller, S. Maaßen, H. Weyhers, F. Specht, and J. S. Lucks, “Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles,” International Journal of Pharmaceutics, vol. 138, no. 1, pp. 85–94, 1996. View at Publisher · View at Google Scholar
  19. R. H. Müller, K. Mäder, and S. Gohla, “Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 161–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Tsai, Y. B. Huang, P. C. Wu et al., “Oral apomorphine delivery from solid lipid nanoparticleswith different monostearate emulsifiers: pharmacokinetic and behavioral evaluations,” Journal of Pharmaceutical Sciences, vol. 100, no. 2, pp. 547–557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Mukherjee, S. Ray, and R. S. Thakur, “Solid lipid nanoparticles: a modern formulation approach in drug delivery system,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 4, pp. 349–358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. K. Rawat, A. Jain, and S. Singh, “In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats,” Journal of Pharmaceutical Sciences, vol. 100, no. 6, pp. 2406–2417, 2011. View at Publisher · View at Google Scholar
  23. C.-F. Luo, M. Yuan, M.-S. Chen et al., “Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration,” International Journal of Pharmaceutics, vol. 410, no. 1-2, pp. 138–144, 2011. View at Publisher · View at Google Scholar
  24. L. Hu, Q. Xing, J. Meng, and C. Shang, “Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles,” AAPS PharmSciTech, vol. 11, no. 2, pp. 582–587, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. B. Souto and R. H. Müller, “Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes,” Handbook of Experimental Pharmacology, vol. 197, pp. 115–141, 2010. View at Publisher · View at Google Scholar
  26. B. W. K. Siekmann, “Submicron lipid suspensions (solid lipid nanoparticles) versus lipid nanoemulsions: similarities and differences,” Amesterdam, The Netherlands, 1998.
  27. R. H. Müller, W. Mehnert, and E. B. Souto, “Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery,” Hong-Kong, 2005.
  28. S. A. Wissing, O. Kayser, and R. H. Müller, “Solid lipid nanoparticles for parenteral drug delivery,” Advanced Drug Delivery Reviews, vol. 56, no. 9, pp. 1257–1272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Das and A. Chaudhury, “Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery,” AAPS PharmSciTech, vol. 12, no. 1, pp. 62–76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Bunjes, “Lipid nanoparticles for the delivery of poorly water-soluble drugs,” Journal of Pharmacy and Pharmacology, vol. 62, no. 11, pp. 1637–1645, 2010. View at Publisher · View at Google Scholar
  31. S. Singh, A. K. Dobhal, A. Jain, J. K. Pandit, and S. Chakraborty, “Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine,” Chemical and Pharmaceutical Bulletin, vol. 58, no. 5, pp. 650–655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. F. Fangueiro, E. Gonzalez-Mira, P. Martins-Lopes, M. A. Egea, M. L. Garcia, and S. B. Souto, “A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing,” Pharmaceutical Development and Technology. In press.
  33. S. Das, W. K. Ng, P. Kanaujia, S. Kim, and R. B. H. Tan, “Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables,” Colloids and Surfaces B, vol. 88, no. 1, pp. 483–489, 2011. View at Publisher · View at Google Scholar
  34. C. Olbrich, A. Gessner, O. Kayser, and R. H. Müller, “Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate,” Journal of Drug Targeting, vol. 10, no. 5, pp. 387–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Sek, C. J. H. Porter, A. M. Kaukonen, and W. N. Charman, “Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products,” Journal of Pharmacy and Pharmacology, vol. 54, no. 1, pp. 29–41, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. R. H. Müller and C. M. Keck, “Challenges and solutions for the delivery of biotech drugs—a review of drug nanocrystal technology and lipid nanoparticles,” Journal of Biotechnology, vol. 113, no. 1–3, pp. 151–170, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. E. B. Souto, S. Doktorovova, and P. Boonme, “Lipid nanocarriers-based semisolids: review on materials and end product formulations,” Journal of Drug Delivery Science and Technology, vol. 21, pp. 43–54, 2011. View at Google Scholar
  38. C. Liu, D. Liu, F. Bai, J. Zhang, and N. Zhang, “In vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil delivery,” Drug Delivery, vol. 17, no. 5, pp. 352–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Shukla, S. Chakraborty, S. Singh, and B. Mishra, “Lipid-based oral multiparticulate formulations-advantages, technological advances and industrial applications,” Expert Opinion on Drug Delivery, vol. 8, no. 2, pp. 207–224, 2011. View at Publisher · View at Google Scholar
  40. H. Weyhers, S. Ehlers, H. Hahn, E. B. Souto, and R. H. Müller, “Solid lipid nanoparticles (SLN)—Effects of lipid composition on in vitro degradation and in vivo toxicity,” Pharmazie, vol. 61, no. 6, pp. 539–544, 2006. View at Google Scholar · View at Scopus
  41. W. Mehnert and K. Mäder, “Solid lipid nanoparticles: production, characterization and applications,” Advanced Drug Delivery Reviews, vol. 47, no. 2-3, pp. 165–196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. V. Jenning, A. F. Thünemann, and S. H. Gohla, “Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids,” International Journal of Pharmaceutics, vol. 199, no. 2, pp. 167–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Montisci, A. Dembri, G. Giovannuci, H. Chacun, D. Duchêne, and G. Ponchel, “Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats,” Pharmaceutical Research, vol. 18, no. 6, pp. 829–837, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Zimmermann and R. H. Müller, “Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 52, no. 2, pp. 203–210, 2001. View at Publisher · View at Google Scholar
  45. H. Reithmeier, J. Herrmann, and A. Göpferich, “Development and characterization of lipid microparticles as a drug carrier for somatostatin,” International Journal of Pharmaceutics, vol. 218, no. 1-2, pp. 133–143, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Kristl, B. Volk, P. Ahlin, K. Gombač, and M. Šentjurc, “Interactions of solid lipid nanoparticles with model membranes and leukocytes studied by EPR,” International Journal of Pharmaceutics, vol. 256, no. 1-2, pp. 133–140, 2003. View at Publisher · View at Google Scholar
  47. P. M. Bummer, “Physical chemical considerations of lipid-based oral drug delivery—solid lipid nanoparticles,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 21, no. 1, pp. 1–19, 2004. View at Google Scholar · View at Scopus
  48. V. Kakkar, S. Singh, D. Singla, and I. P. Kaur, “Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin,” Molecular Nutrition and Food Research, vol. 55, no. 3, pp. 495–503, 2011. View at Publisher · View at Google Scholar
  49. M. K. Rawat, A. Jain, and S. Singh, “Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation,” Journal of Pharmaceutical Sciences, vol. 100, no. 6, pp. 2366–2378, 2011. View at Publisher · View at Google Scholar
  50. R. Yang, R. Gao, F. Li, H. He, and X. Tang, “The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process,” Drug Development and Industrial Pharmacy, vol. 37, no. 2, pp. 139–148, 2011. View at Publisher · View at Google Scholar
  51. H. Heiati, R. Tawashi, and N. C. Phillips, “Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization,” Journal of Microencapsulation, vol. 15, no. 2, pp. 173–184, 1998. View at Google Scholar · View at Scopus
  52. A. E. B. Yassin, M. D. Khalid Anwer, H. A. Mowafy, I. M. El-Bagory, M. A. Bayomi, and I. A. Alsarra, “Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer,” International Journal of Medical Sciences, vol. 7, no. 6, pp. 398–408, 2010. View at Google Scholar · View at Scopus
  53. V. Teeranachaideekul, E. Souto, R. Müller, and V. B. Junyaprasert, “Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels),” Journal of Microencapsulation, vol. 25, no. 2, pp. 111–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Priano, G. P. Zara, N. El-Assawy et al., “Baclofen-loaded solid lipid nanoparticles: preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 79, no. 1, pp. 135–141, 2011. View at Publisher · View at Google Scholar
  55. M. Krzic, M. Sentjurc, and J. Kristl, “Improved skin oxygenation after benzyl nicotinate application in different carriers as measured by EPR oximetry in vivo,” Journal of Controlled Release, vol. 70, no. 1-2, pp. 203–211, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Martins, A. C. Silva, D. C. Ferreira, and E. B. Souto, “Improving oral absorption of samon calcitonin by trimyristin lipid nanoparticles,” Journal of Biomedical Nanotechnology, vol. 5, no. 1, pp. 76–83, 2009. View at Publisher · View at Google Scholar
  57. X. Zhang, W. Pan, L. Gan, C. Zhu, Y. Gan, and S. Nie, “Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying,” Chemical and Pharmaceutical Bulletin, vol. 56, no. 12, pp. 1645–1650, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. Z. R. Huang, S. C. Hua, Y. L. Yang, and J. Y. Fang, “Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion,” Acta Pharmacologica Sinica, vol. 29, no. 9, pp. 1094–1102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Manjunath and V. Venkateswarlu, “Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration,” Journal of Controlled Release, vol. 107, no. 2, pp. 215–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. J. K. Varia, S. S. Dodiya, and K. K. Sawant, “Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization,” Current Drug Delivery, vol. 5, no. 1, pp. 64–69, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. R. H. Müller, S. A. Runge, V. Ravelli, A. F. Thünemann, W. Mehnert, and E. B. Souto, “Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 68, no. 3, pp. 535–544, 2008. View at Publisher · View at Google Scholar
  62. G. Chen, S. X. Hou, P. Hu, Q. H. Hu, D. D. Guo, and Y. Xiao, “In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window,” Journal of Southern Medical University, vol. 28, no. 6, pp. 1022–1024, 2008. View at Google Scholar · View at Scopus
  63. G. Abdelbary and R. H. Fahmy, “Diazepam-Loaded solid lipid nanoparticles: design and characterization,” AAPS PharmSciTech, vol. 10, no. 1, pp. 211–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. K. W. Kang, M. K. Chun, O. Kim et al., “Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy,” Nanomedicine, vol. 6, no. 2, pp. 210–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Q. Hu, Y. Hong, and H. Yuan, “Preparation and characterization of solid lipid nanoparticles containing peptide,” International Journal of Pharmaceutics, vol. 273, no. 1-2, pp. 29–35, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. L. B. Jensen, E. Magnussson, L. Gunnarsson, C. Vermehren, H. M. Nielsen, and K. Petersson, “Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles,” International Journal of Pharmaceutics, vol. 390, no. 1, pp. 53–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. S. G. Potta, S. Minemi, R. K. Nukala et al., “Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility,” Journal of Microencapsulation, vol. 28, no. 1, pp. 74–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Ma, X. Dong, C. L. Swadley et al., “Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia,” Journal of Biomedical Nanotechnology, vol. 5, no. 2, pp. 151–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Kheradmandnia, E. Vasheghani-Farahani, M. Nosrati, and F. Atyabi, “Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax,” Nanomedicine, vol. 6, no. 6, pp. 753–759, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. M. R. Aji Alex, A. J. Chacko, S. Jose, and E. B. Souto, “Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting,” European Journal of Pharmaceutical Sciences, vol. 42, no. 1-2, pp. 11–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. V. B. Patravale and A. V. Ambarkhane, “Study of solid lipid nanoparticles with respect to particle size distribution and drug loading,” Pharmazie, vol. 58, no. 6, pp. 392–395, 2003. View at Google Scholar · View at Scopus
  72. Q. Lv, A. Yu, Y. Xi et al., “Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery,” International Journal of Pharmaceutics, vol. 372, no. 1-2, pp. 191–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Yuan, L. L. Wang, Y. Z. Du, J. You, F. Q. Hu, and S. Zeng, “Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification,” Colloids and Surfaces B, vol. 60, no. 2, pp. 174–179, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Cavalli, E. Peira, O. Caputo, and M. R. Gasco, “Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins,” International Journal of Pharmaceutics, vol. 182, no. 1, pp. 59–69, 1999. View at Publisher · View at Google Scholar
  75. Y. Hong, F. Q. Hu, and H. Yuan, “Effect of PEG2000 on drug delivery characterization from solid lipid nanoparticles,” Pharmazie, vol. 61, no. 4, pp. 312–315, 2006. View at Google Scholar · View at Scopus
  76. X.-M. Xu, Y.-S. Wang, R.-Y. Chen et al., “Formulation and pharmacokinetic evaluation of tetracycline-loaded solid lipid nanoparticles for subcutaneous injection in mice,” Chemical and Pharmaceutical Bulletin, vol. 59, no. 2, pp. 260–265, 2011. View at Publisher · View at Google Scholar
  77. E. Başaran, M. Demirel, B. Sirmagül, and Y. Yazan, “Cyclosporine—a incorporated cationic solid lipid nanoparticles for ocular delivery,” Journal of Microencapsulation, vol. 27, no. 1, pp. 37–47, 2010. View at Publisher · View at Google Scholar
  78. K. Vivek, H. Reddy, and R. S. R. Murthy, “Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles,” AAPS PharmSciTech, vol. 8, no. 4, article no. 83, 2007. View at Google Scholar · View at Scopus
  79. M. Shah, K. Chuttani, A. K. Mishra, and K. Pathak, “Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies,” Drug Development and Industrial Pharmacy, vol. 37, no. 5, pp. 526–537, 2011. View at Publisher · View at Google Scholar
  80. A. del Pozo-Rodríguez, D. Delgado, M. A. Solinís et al., “Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration,” International Journal of Pharmaceutics, vol. 385, no. 1-2, pp. 157–162, 2010. View at Publisher · View at Google Scholar
  81. J. Zhang and E. Smith, “Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles,” Journal of Pharmaceutical Sciences, vol. 100, no. 3, pp. 896–903, 2011. View at Publisher · View at Google Scholar
  82. L. Montenegro, A. Campisi, M. G. Sarpietro et al., “In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain,” Drug Development and Industrial Pharmacy, vol. 37, no. 6, pp. 737–746, 2011. View at Publisher · View at Google Scholar
  83. S. Xie, L. Zhu, Z. Dong, Y. Wang, X. Wang, and W. Zhou, “Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles,” International Journal of Nanomedicine, vol. 6, pp. 547–555, 2011. View at Google Scholar
  84. L. Battaglia, M. Gallarate, R. Cavalli, and M. Trotta, “Solid lipid nanoparticles produced through a coacervation method,” Journal of Microencapsulation, vol. 27, no. 1, pp. 78–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. N. Schöler, H. Hahn, R. H. Müller, and O. Liesenfeld, “Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages,” International Journal of Pharmaceutics, vol. 231, no. 2, pp. 167–176, 2002. View at Publisher · View at Google Scholar
  86. D. J. Hauss, “Oral lipid-based formulations,” Advanced Drug Delivery Reviews, vol. 59, no. 7, pp. 667–676, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. T. M. Goppert and R. H. Muller, “Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns,” Journal of Drug Targeting, vol. 13, no. 3, pp. 179–187, 2005. View at Google Scholar
  88. W. C. Griffin, “Classification of surface-active agents by HLB,” Journal of the Society of Cosmetic Chemists, vol. 1, p. 311, 1949. View at Google Scholar
  89. R. Kinget, “Classification of the most important surface active agents being used for the formulation of drugs and cosmetic products,” Farmaceutisch Tijdschrift voor Belgie, vol. 75, no. 4, pp. 3–15, 1998. View at Google Scholar · View at Scopus
  90. W. C. Griffin, “Calculation of HLB valuess of nonionic surfactants,” Journal of the Society of Cosmetic Chemists, vol. 5, pp. 249–256, 1954. View at Google Scholar
  91. T. Schmidts, D. Dobler, C. Nissing, and F. Runkel, “Influence of hydrophilic surfactants on the properties of multiple W/O/W emulsions,” Journal of Colloid and Interface Science, vol. 338, no. 1, pp. 184–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Varshosaz, M. Tabbakhian, and M. Y. Mohammadi, “Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability,” Journal of Liposome Research, vol. 20, no. 4, pp. 286–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Jain, S. Jain, P. Khare, A. Gulbake, D. Bansal, and S. K. Jain, “Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent,” Drug Delivery, vol. 17, no. 6, pp. 443–451, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. M. A. Kalam, Y. Sultana, A. Ali, M. Aqil, A. K. Mishra, and K. Chuttani, “Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system,” Journal of Drug Targeting, vol. 18, no. 3, pp. 191–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. T. M. Göppert and R. H. Müller, “Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting,” International Journal of Pharmaceutics, vol. 302, no. 1-2, pp. 172–186, 2005. View at Publisher · View at Google Scholar
  96. J. Kristl, K. Teskac, M. Milek, and I. Mlinaric-Rascan, “Surface active stabilizer Tyloxapol in colloidal dispersions exerts cytostatic effects and apoptotic dismissal of cells,” Toxicology and Applied Pharmacology, vol. 232, no. 2, pp. 218–225, 2008. View at Publisher · View at Google Scholar
  97. H. Thrandur, T. S. Awad, K. Kristberg, A. D. Eric, J. M. A. David, and W. Jochen, “Impact of surfactant properties on oxidative stability of β-carotene encapsulated within solid lipid nanoparticles,” Journal of Agricultural and Food Chemistry, vol. 57, no. 17, pp. 8033–8040, 2009. View at Publisher · View at Google Scholar
  98. J. Liu, T. Gong, H. Fu et al., “Solid lipid nanoparticles for pulmonary delivery of insulin,” International Journal of Pharmaceutics, vol. 356, no. 1-2, pp. 333–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Bunjes, M. H. J. Koch, and K. Westesen, “Influence of emulsifiers on the crystallization of solid lipid nanoparticles,” Journal of Pharmaceutical Sciences, vol. 92, no. 7, pp. 1509–1520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Trotta, F. Debernardi, and O. Caputo, “Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique,” International Journal of Pharmaceutics, vol. 257, no. 1-2, pp. 153–160, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. T. Wang, N. Wang, Y. Zhang, W. Shen, X. Gao, and T. Li, “Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles,” Colloids and Surfaces B, vol. 79, no. 1, pp. 254–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. C. Olbrich, N. Schöler, K. Tabatt, O. Kayser, and R. H. Müller, “Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages—impact of phagocytosis on viability and cytokine production,” Journal of Pharmacy and Pharmacology, vol. 56, no. 7, pp. 883–891, 2004. View at Publisher · View at Google Scholar
  103. Z. Rahman, A. S. Zidan, and M. A. Khan, “Non-destructive methods of characterization of risperidone solid lipid nanoparticles,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 1, pp. 127–137, 2010. View at Publisher · View at Google Scholar
  104. S. Chakraborty, D. Shukla, P. R. Vuddanda, B. Mishra, and S. Singh, “Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles,” Colloids and Surfaces B, vol. 81, no. 2, pp. 563–569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. D. Pandita, A. Ahuja, T. Velpandian, V. Lather, T. Dutta, and R. K. Khar, “Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique,” Pharmazie, vol. 64, no. 5, pp. 301–310, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. R. Li, J. S. Eun, and M.-K. Lee, “Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration,” Archives of Pharmacal Research, vol. 34, no. 2, pp. 331–337, 2011. View at Publisher · View at Google Scholar
  107. R. Mauludin, R. H. Muller, and C. M. Keck, “Development of an oral rutin nanocrystal formulation,” International Journal of Pharmaceutics, vol. 370, no. 1-2, pp. 202–209, 2009. View at Google Scholar
  108. S. Xie, L. Zhu, Z. Dong et al., “Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids,” Colloids and Surfaces B, vol. 83, no. 2, pp. 382–387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh, “Lipid—an emerging platform for oral delivery of drugs with poor bioavailability,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 73, no. 1, pp. 1–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. Luo, D. Chen, L. Ren, X. Zhao, and J. Qin, “Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability,” Journal of Controlled Release, vol. 114, no. 1, pp. 53–59, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. J. K. Vasir, K. Tambwekar, and S. Garg, “Bioadhesive microspheres as a controlled drug delivery system,” International Journal of Pharmaceutics, vol. 255, no. 1-2, pp. 13–32, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Xie, B. Pan, M. Wang et al., “Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles,” Nanomedicine, vol. 5, no. 5, pp. 693–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. C. Han, C. M. Qi, B. K. Zhao et al., “Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies,” Journal of Veterinary Pharmacology and Therapeutics, vol. 32, no. 2, pp. 116–123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. D. Pandita, A. Ahuja, V. Lather et al., “Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel,” AAPS PharmSciTech, vol. 12, no. 2, pp. 712–722, 2011. View at Publisher · View at Google Scholar
  115. H. Yuan, J. Chen, Y. Z. Du, F. Q. Hu, S. Zeng, and H. L. Zhao, “Studies on oral absorption of stearic acid SLN by a novel fluorometric method,” Colloids and Surfaces B, vol. 58, no. 2, pp. 157–164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. T. G. Smijs and J. A. Bouwstra, “Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact,” Journal of Biomedical Nanotechnology, vol. 6, pp. 469–484, 2010. View at Google Scholar
  117. H. L. Karlsson, “The comet assay in nanotoxicology research,” Analytical and Bioanalytical Chemistry, vol. 398, no. 2, pp. 651–666, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. C. F. Jones and D. W. Grainger, “In vitro assessments of nanomaterial toxicity,” Advanced Drug Delivery Reviews, vol. 61, no. 6, pp. 438–456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. A. C. Silva, E. González-Mira, M. L. García et al., “Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound,” Colloids and Surfaces B, vol. 86, no. 1, pp. 158–165, 2011. View at Publisher · View at Google Scholar
  120. R. H. Müller, D. Rühl, S. Runge, K. Schulze-Forster, and W. Mehnert, “Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant,” Pharmaceutical Research, vol. 14, no. 4, pp. 458–462, 1997. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Nassimi, C. Schleh, H. D. Lauenstein et al., “A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 75, no. 2, pp. 107–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  122. V. Meunier, M. Bourrie, Y. Berger, and G. Fabre, “The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications,” Cell Biology and Toxicology, vol. 11, no. 3-4, pp. 187–194, 1995. View at Publisher · View at Google Scholar · View at Scopus
  123. V. Mathur, Y. Satrawala, M. S. Rajput, P. Kumar, P. Shrivastava, and A. Vishvkarma, “Solid lipid nanoparticles in cancer therapy,” International Journal of Drug Delivery, no. 2, pp. 192–199, 2010. View at Google Scholar
  124. M. Harms and C. C. Müller-Goymann, “Solid lipid nanoparticles for drug delivery,” Journal of Drug Delivery Science and Technology, vol. 1, no. 21, 2011. View at Google Scholar
  125. U. H. Cegla, “Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients,” Praxis und Klinik der Pneumologie, vol. 42, no. 9, pp. 715–721, 1988. View at Google Scholar
  126. P. Speiser, Lipid nanopellets as carrier system for drugs for oral administration, 1990.
  127. M. Üner and G. Yener, “Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives,” International Journal of Nanomedicine, vol. 3, no. 2, 2007. View at Google Scholar
  128. W. Wei, S. J. Shi, J. Liu et al., “Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application,” Journal of Drug Targeting, vol. 18, no. 7, pp. 557–566, 2010. View at Google Scholar
  129. B. Sarmento, S. Martins, D. Ferreira, and E. B. Souto, “Oral insulin delivery by means of solid lipid nanoparticles,” International Journal of Nanomedicine, vol. 2, no. 4, pp. 743–749, 2007. View at Google Scholar